Metraipolis › archive › dc_2c3486d53ffc
Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS — Europe PMC PMID:42449162
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42449162
- DOI
- 10.1002/alz.71659
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T14:13:33.870Z
- SHA-256 of the archived text
510c26cdb476e40475915202f6c5d6e37bdf218b9aad05c5a8422ccba94dc15e- Stable URL of this page
https://metraipolis.com/documento/dc_2c3486d53ffc
How to cite
Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS — Europe PMC PMID:42449162 — Europe PMC (en), https://europepmc.org/article/MED/42449162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c3486d53ffc (Metraipolis archive dc_2c3486d53ffc, sha256 510c26cdb476e40475915202f6c5d6e37bdf218b9aad05c5a8422ccba94dc15e)
BibTeX
@misc{dc2c3486d53ffc,
title = {Blood biomarkers predict conversion from cognitively stable to mild cognitive impairment or Alzheimer's disease in Down syndrome at 16-month follow-up in ABC-DS — Europe PMC PMID:42449162},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42449162},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c3486d53ffc; sha256 510c26cdb476e40475915202f6c5d6e37bdf218b9aad05c5a8422ccba94dc15e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449162. Agents can read the archived copy with the MCP tool read_document.